Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...
London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...
The EU's second-highest court, the General Court of the European Union, ruled partially against the Commission’s decision to ...